Table 1.
Clinical, Histological, and CGH Karyotype Findings for 24 ACCs.
| Case | Age/Sex | Tumor Site | Grade/Stage | CGH Karyotype | |
| Losses | Gains | ||||
| 1 | 49/F | trachea | 1/I | 6q22.3-q23, X | - |
| 2 | 68/M | submandibular | 1/I | N | N |
| 3 | 54/F | trachea | 1/I | - | 15, 16, 17, 19 |
| 4 | 70/M | soft palate | 1/I | 6q23-qter, 9q31-qter, 13q14-q22 | 19 |
| 5 | 54/F | submandibular | 1/II | 8q11-q13, 9p | 3q13.3-q23 |
| 6 | 53/M | maxilla | 1/III | 6q23-qter | - |
| 7 | 65/M | parotid | 1/IV | 13q21-qter, 14 | - |
| 8 | 64/M | maxilla | 1/IV | 12q12-q14 | 16, 19 |
| 9 | 58/F | parotid | 1/IV | 9p21-pter | 19 |
| 10 | 57/F | soft palate | 2/I | N | N |
| 11 | 50/F | floor of mouth | 2/I | 12q21.3-qter | - |
| 12 | 36/F | bronchus | 2/IA | 6q11-q23, 12q12-q14, 13q14-q31 | 19 |
| 13 | 66/F | nasal septum | 2/II | 12q12-q15 | - |
| 14 | 64/M | parotid | 2/IV | 12q12-q21.2, 13q14-q31 | - |
| 15 | 33/F | parotid | 2/IV | N | N |
| 16 | 48/F | tongue base | 2/IVA | N | N |
| 17 | 43/F | trachea | 2/IIIB | 14 | 22 |
| 18 | 72/F | tongue | 2/unknown | 12q12-q13 | - |
| 19 | 69/M | soft palate | 3/II | - | 8 |
| 20 | 57/F | parotid | 3/IV | 6q11-q23, 9p21-pter, 12q15-q21, 13q13-q31 | 19 |
| 21 | 54/F | maxilla | 3/IVA | 1p35-pter, 1q41-qter, 5, 11p | 1p11-p34, 1q11-q32, 7, 9p, 11q12-q13 |
| 22 | 50/M | palate | 3/IVC | 6q23-qter, 9q, 11q21-q23 | 9p, 19, 22 |
| 23 | 73/F | lacrimal gland | 3/T2 N0 M0 | 1p33-pter, Xp21-pter, 6q22.2-q23, 7p13-p21.2, 12q12-q13, 13, 16q | 1p22-qter, 7q, 19 |
| 24 | 63/F | lacrimal gland | 3/T4a N0 M0 | 5q12-q21 | 19 |
M: male, F: female, N: normal.